Embedded Files
Help researchers learn more about managing ADHD symptoms in youth with autism
Physicians at the Glenrose Rehabilitation Hospital and Royal Alexandra Hospital are working together with 11 other sites in Canada and the United States to learn more about the effectiveness of ADHD medication in children and teens with autism spectrum disorder.
Participants are closely monitored over a period of 16 weeks throughout their medication trial. Caregivers provide verbal and written feedback throughout the process to guide decision making and help researchers better understand their child’s responses to the ADHD medication.
Participants are recruited through the Neurodevelopmental and Autism Consultation Service (NDACS) at the Glenrose or the Child Ambulatory Clinic at the Royal Alexandra Hospital.
What is the purpose of this study?
What is the purpose of this study?
The purpose of this study is to help researchers understand the benefits and side effects of medicine often used to treat attention deficit hyperactivity disorder (ADHD) in children with autism.
Who can take part in this study?
Your child may be able to join if they:
Are 6-17 years old
Have autism spectrum disorder and ADHD symptoms
Can take medication
Have a parent/guardian who often spends time with them
What will happen during the study?
The study includes 9 visits. Most can be done over phone or video calls. The entire study takes up to 19 weeks. Study visits include:
Questionnaire
Blood pressure, pulse, height, and weight
Medication review
Medical history
Talking with study doctor
Will we be paid for the study?
Yes, an incentive will be offered in appreciation of your participation in the study.
Or visit the AWARE website at awareresearch.org to learn more.
Report abuse